Zim Laboratories Ltd Share Price ₹114 | P/E 75.2

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of Zim Laboratories Ltd

Quarter-by-quarter operating performance

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Sales +	105.41	67.44	85.83	96.29	117.86	81.82	92.14	96.33	108.73	71.76	88.71	108.66	105.27
Expenses +	89.96	62.62	76.50	84.75	102.21	73.78	82.61	84.77	94.13	67.51	82.95	95.85	98.08
Operating Profit	15.45	4.82	9.33	11.54	15.65	8.04	9.53	11.56	14.60	4.25	5.76	12.81	7.19
OPM %	14.66%	7.15%	10.87%	11.98%	13.28%	9.83%	10.34%	12.00%	13.43%	5.92%	6.49%	11.79%	6.83%
Other Income +	0.69	1.12	1.42	1.11	1.53	1.00	1.32	1.75	1.71	1.48	2.04	1.70	6.16
Interest	1.27	1.73	1.22	1.70	2.28	2.86	2.89	2.73	2.91	3.30	3.16	3.43	3.31
Depreciation	4.93	4.03	4.09	3.94	3.91	4.94	5.00	4.88	5.29	4.86	4.98	5.03	5.10
Profit before tax	9.94	0.18	5.44	7.01	10.99	1.24	2.96	5.70	8.11	-2.43	-0.34	6.05	4.94
Tax %	27.16%	-22.22%	23.71%	31.81%	26.48%	27.42%	19.59%	30.00%	39.70%	-22.63%	23.53%	27.27%	24.29%
Net Profit +	7.24	0.23	4.15	4.78	8.09	0.90	2.38	4.00	4.88	-1.87	-0.42	4.40	3.74
EPS in Rs	1.49	0.05	0.85	0.98	1.66	0.18	0.49	0.82	1.00	-0.38	-0.09	0.90	0.70

Financials of Zim Laboratories Ltd

Annual income statement trend

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Sales +	266	269	235	273	335	278	307	333	399	367	379	374
Expenses +	278	239	203	238	293	255	268	292	347	326	335	344
Operating Profit	-12	30	32	35	42	23	40	41	52	41	44	30
OPM %	-4%	11%	13%	13%	13%	8%	13%	12%	13%	11%	12%	8%
Other Income +	2	-2	5	9	2	5	-3	4	6	5	6	11
Interest	10	14	10	9	11	13	11	8	6	7	11	13
Depreciation	7	9	9	10	11	14	16	16	17	16	20	20
Profit before tax	-27	5	18	25	22	0	10	21	35	24	18	8
Tax %	-19%	5%	-6%	23%	30%	-4,600%	28%	31%	31%	27%	32%	29%
Net Profit +	-22	5	19	19	15	3	7	15	24	17	12	6
EPS in Rs					3.17	0.68	1.50	2.99	5.01	3.54	2.50	1.09
Dividend Payout %	0%	16%	4%	4%	5%	0%	0%	0%	0%	0%	0%	0%

Financials of Zim Laboratories Ltd

Capital structure and asset base

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	8	8	8	8	16	16	16	16	49	49	49	54
Reserves	86	91	110	129	135	138	145	159	152	190	204	243
Borrowings +	93	96	81	81	77	90	82	53	62	112	118	126
Other Liabilities +	78	61	60	81	100	82	82	112	79	96	102	118
Total Liabilities	265	256	259	298	328	325	325	342	342	447	472	539
Fixed Assets +	87	92	89	94	106	116	107	106	109	161	164	199
CWIP	6	3	4	8	13	10	11	12	27	42	70	59
Investments	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets +	172	161	166	196	209	200	208	224	206	244	237	282
Total Assets	265	256	259	298	328	325	325	342	342	447	472	539

Financials of Zim Laboratories Ltd

Operating, investing and financing cash movement

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity +	22	32	37	35	22	32	49	38	16	41	50
Cash from Investing Activity +	-12	-7	-26	-21	-19	-6	-14	-36	-73	-40	-56
Cash from Financing Activity +	-10	-25	-10	-15	-2	-26	-33	1	60	-9	28
Net Cash Flow	-0	-0	1	-1	1	-0	2	3	3	-8	21
Free Cash Flow	9	24	8	15	3	25	34	2	-57	1	11
CFO/OP	77%	109%	117%	85%	119%	83%	121%	87%	46%	92%	165%

Financials of Zim Laboratories Ltd

Working capital efficiency and return ratios

	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	111	120	137	119	101	89	86	98	87	100	103	106
Inventory Days	93	87	108	134	126	144	125	171	99	173	188	207
Days Payable	129	109	137	172	165	168	149	185	107	133	151	161
Cash Conversion Cycle	75	99	108	81	63	65	62	85	79	140	140	152
Working Capital Days	38	34	54	37	39	46	49	67	67	57	60	41
ROCE %		13%	14%	14%	15%	5%	11%	12%	17%	10%	8%	5%